Baxter announces u.s. fda 510(k) clearance of ak 98 hemodialysis machine

Deerfield, ill.--(business wire)--baxter international inc. (nyse:bax), a global innovator in renal care, today announced u.s. food and drug administration (fda) clearance of its next-generation artificial kidney 98 (ak 98) dialysis machine, which is designed to be a portable and easy-to-use system to administer hemodialysis (hd) treatments. ak 98 offers encrypted, two-way connectivity, which enables the system to pull prescriptions directly from the electronic medical record (emr) for simplifi
BAX Ratings Summary
BAX Quant Ranking